In this study, refinements of diagnoses were most frequently reported due to either the presence or absence of MYD88 mutations in distinguishing LPL from MZL or the presence of NOTCH2 and TNFAIP3 mutations in favoring a diagnosis of MZL over LPL [220]. Here, MYD88 is linked to marginal zone lymphoma.